Literature DB >> 28684544

Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs.

Insa Bultmann-Mellin1, Katharina Dinger1,2, Carolin Debuschewitz1, Katharina M A Loewe1, Yvonne Melcher1, Miro T W Plum1, Sarah Appel2, Gunter Rappl3,4, Sebastian Willenborg5, Astrid C Schauss6, Christian Jüngst6, Marcus Krüger3,7,8, Sven Dressler9, Tomoyuki Nakamura10, Frank Wempe11, Miguel A Alejandre Alcázar2, Anja Sterner-Kock12.   

Abstract

Deficiency of the extracellular matrix protein latent transforming growth factor-β (TGF-β)-binding protein-4 (LTBP4) results in lack of intact elastic fibers, which leads to disturbed pulmonary development and lack of normal alveolarization in humans and mice. Formation of alveoli and alveolar septation in pulmonary development requires the concerted interaction of extracellular matrix proteins, growth factors such as TGF-β, fibroblasts, and myofibroblasts to promote elastogenesis as well as vascular formation in the alveolar septae. To investigate the role of LTBP4 in this context, lungs of LTBP4-deficient (Ltbp4-/-) mice were analyzed in close detail. We elucidate the role of LTBP4 in pulmonary alveolarization and show that three different, interacting mechanisms might contribute to alveolar septation defects in Ltbp4-/- lungs: 1) absence of an intact elastic fiber network, 2) reduced angiogenesis, and 3) upregulation of TGF-β activity resulting in profibrotic processes in the lung.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  alveolar septation; angiogenesis; elastic fibers; latent transforming growth factor-β-binding protein-4; pulmonary fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28684544     DOI: 10.1152/ajplung.00031.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

1.  Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis.

Authors:  Shuin Park; Sara Ranjbarvaziri; Fides D Lay; Peng Zhao; Mark J Miller; Jasmeet S Dhaliwal; Adriana Huertas-Vazquez; Xiuju Wu; Rong Qiao; Justin M Soffer; Christoph Rau; Yibin Wang; Hanna K A Mikkola; Aldons J Lusis; Reza Ardehali
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

Review 2.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

Review 3.  The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly.

Authors:  Alan R F Godwin; Mukti Singh; Michael P Lockhart-Cairns; Yasmene F Alanazi; Stuart A Cain; Clair Baldock
Journal:  Matrix Biol       Date:  2019-06-18       Impact factor: 11.583

Review 4.  Two novel compound heterozygous variants of LTBP4 in a Chinese infant with cutis laxa type IC and a review of the related literature.

Authors:  Qiang Zhang; Zailong Qin; Shang Yi; Hao Wei; Xun Zhao Zhou; Jiasun Su
Journal:  BMC Med Genomics       Date:  2020-12-10       Impact factor: 3.063

5.  LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure.

Authors:  Chi-Ting Su; Tzu-Ming Jao; Zsolt Urban; Yue-Jhu Huang; Daniel H W See; Yao-Chou Tsai; Wei-Chou Lin; Jenq-Wen Huang
Journal:  Cell Death Dis       Date:  2021-10-13       Impact factor: 9.685

6.  Physiology and Proteomic Basis of Lung Adaptation to High-Altitude Hypoxia in Tibetan Sheep.

Authors:  Pengfei Zhao; Shaobin Li; Zhaohua He; Fangfang Zhao; Jiqing Wang; Xiu Liu; Mingna Li; Jiang Hu; Zhidong Zhao; Yuzhu Luo
Journal:  Animals (Basel)       Date:  2022-08-19       Impact factor: 3.231

Review 7.  LTBP4 in Health and Disease.

Authors:  Chi-Ting Su; Zsolt Urban
Journal:  Genes (Basel)       Date:  2021-05-23       Impact factor: 4.096

8.  miR-16 integrates signal pathways in myofibroblasts: determinant of cell fate necessary for fibrosis resolution.

Authors:  Qin Pan; Can-Jie Guo; Qing-Yang Xu; Jin-Zhi Wang; Han Li; Chun-Hua Fang
Journal:  Cell Death Dis       Date:  2020-08-07       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.